Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Baxter
Medtronic
Merck

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PERAMPANEL

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Perampanel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00368472 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures Completed Eisai Inc. Phase 2 2006-10-01 The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures.
NCT00505284 An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Limited Phase 2/Phase 3 2007-06-01 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
NCT00505284 An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Completed Eisai Inc. Phase 2/Phase 3 2007-06-01 The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Perampanel

Condition Name

Condition Name for Perampanel
Intervention Trials
Epilepsy 11
Refractory Partial Seizures 4
Healthy 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Perampanel
Intervention Trials
Seizures 19
Epilepsy 16
Amyotrophic Lateral Sclerosis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Perampanel

Trials by Country

Trials by Country for Perampanel
Location Trials
United States 153
Japan 43
China 16
Spain 13
Canada 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Perampanel
Location Trials
Florida 10
New York 9
Maryland 8
Colorado 8
Arizona 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Perampanel

Clinical Trial Phase

Clinical Trial Phase for Perampanel
Clinical Trial Phase Trials
Phase 4 9
Phase 3 11
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Perampanel
Clinical Trial Phase Trials
Completed 20
Recruiting 15
Not yet recruiting 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Perampanel

Sponsor Name

Sponsor Name for Perampanel
Sponsor Trials
Eisai Inc. 33
Eisai Co., Ltd. 7
Eisai Limited 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Perampanel
Sponsor Trials
Industry 45
Other 15
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Johnson and Johnson
Colorcon
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.